Toggle navigation
Home
Search
Services
Blog
Contact
About
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C.
Ribogene, Inc., Hayward, CA, United States
Search 4 grants from Julia Watson
Search grants from Ribogene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
Contribution of resident stem cells to tumor stroma and vasculature
Paf/CDC Hematologic Cancer Education and Outreach Partnership
Auditory Mechanisms Underlying Speech Understanding
Neurotensin Gene Regulation in Neural Crest Derived Cell
Recently added grants:
Measure the metabolic and genetic factors that determine M. Tuberculosis
Forum on Microbial Threats
Functional analysis of a Group A streptococcal locus important for fitness in soft tissue
Administrative Core
Human Subjects Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA065331-02A1
Application #
2008636
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Ribogene, Inc.
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Related projects
NIH 1997
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
NIH 1996
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
Comments
Be the first to comment on Julia Watson's grant